Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic ...
Introduction Breast cancer is the most common malignancy among women and remains a leading cause of cancer-related mortality worldwide.1 It is a biologically heterogeneous disease composed of multiple subtypes with distinct molecular characteristics, …